Document is current
Any future updates will be listed below
-
Authors
Zhang, Pin
Sun, Tao https://orcid.org/0000-0001-5931-386X
Wang, Ying
Li, Wei
Tong, Zhongsheng
Phadke, Sneha
Feinstein, Trevor
Ma, Wenyue https://orcid.org/0009-0005-1196-8791
Guo, Pengfei
Zhang, Minhua
Yue, Yong
Xu, Binghe https://orcid.org/0000-0003-4195-337X
-
Funding
Funding for this research was provided by:
Laekna Therapeutics
- License Information
-
More Information
Article History
Received: 18 April 2025
Accepted: 28 January 2026
First Online: 6 February 2026
Competing interests
: B.X. discloses receiving advisory fees from Novartis and AstraZeneca. S.P. is a consultant and scientific advisory board member for Starling Biosciences. T.F. is a speaker for AstraZeneca, Sobi, and Sanofi and discloses receiving BeyondSpring’s support for travel. W.M., P.G., M.Z., and Y.Y. are employees of Laekna Therapeutics. The remaining authors declare no competing interests.
